Ami Organics IPO GMP History
Ami Organics IPO has been listed on September 14, 2021 at a listing price of ₹910, against the issue price of ₹610 — a gain of ₹300 (+49.18%). The GMP peaked at ₹150 on 13 September 2021 and reached a low of ₹105 on 2 September 2021. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Ami Organics IPO raised ₹569.64 Cr. through its IPO at a price band of ₹603 to ₹610 per share, with a lot size of 24 shares. The IPO was open for subscription from 01 Sep 2021 to 03 Sep 2021.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 7:27 AM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 13 Sep 2021 | ₹ 150 | — | 25% | — | — |
| 11 Sep 2021 | ₹ 150 | — | 25% | — | — |
| 09 Sep 2021 | ₹ 150 | — | 25% | — | — |
| 08 Sep 2021 | ₹ 150 | ▲ | 25% | — | — |
| 07 Sep 2021 | ₹ 145 | ▲ | 24% | — | — |
| 06 Sep 2021 | ₹ 130 | ▲ | 21% | — | — |
| 04 Sep 2021 | ₹ 120 | ▲ | 20% | — | — |
| 03 Sep 2021 | ₹ 110 | ▲ | 18% | — | — |
| 02 Sep 2021 | ₹ 105 | ▼ | 17% | — | — |
| 01 Sep 2021 | ₹ 125 | — | 20% | — | — |
Ami Organics IPO dates
Key dates from opening to listing. Today is 10 November.
- Open 01 Sep 2021
- Close 03 Sep 2021
- Allotment 08 Sep 2021
- Refund/credit 09 Sep 2021
- Listing 14 Sep 2021
Ami Organics IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹610 |
|---|---|
| GMP-based estimate (pre-listing) | ₹760 (+24.6%) |
| Listing gain / loss | +₹300 per share |
| Listing date | 14 Sep, 2021 |
| Actual listing price | ₹910 (+49.18%) |
Is Ami Organics IPO GMP reliable?
Grey market premium for Ami Organics IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Ami Organics IPO full review for a fundamentals-based assessment before making any grey market trades.
Ami Organics IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Ami Organics IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Ami Organics IPO
Ami Organics Limited was incorporated in 2004. It develops and makes advanced pharmaceutical intermediates for regulated and generic APIs and new chemical entities, and key starting materials for agrochemical and fine chemicals, helped by its acquisition of the business of Gujarat Organics.
It has developed and commercialised over 450 pharma intermediates across 17 key therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. It is one of the major makers of intermediates for APIs such as Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
It supplies more than 150 customers in India and 25 countries, including Laurus Labs, Cadila Healthcare and Cipla. Its three plants at Sachin, Ankleshwar and Jhagadia in Gujarat have an installed capacity of 6,060 MTPA.
The IPO was Rs 569.64 crore, with Rs 200.00 crore of fresh issue and Rs 369.64 crore of offer for sale. Rs 140.00 crore was planned for repaying borrowings and Rs 90.00 crore for working capital.
Frequently asked
What is the GMP of Ami Organics IPO?
The current Grey Market Premium (GMP) of Ami Organics IPO is ₹ 150.
What is the Kostak Price of Ami Organics IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Ami Organics IPO is not available.
What is the Subject to Sauda Price of Ami Organics IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Ami Organics IPO?
Ami Organics IPO listed on September 14, 2021 at ₹910, against the issue price of ₹610 — a gain of +49.18%.
How did the GMP of Ami Organics IPO trend before listing?
The GMP of Ami Organics IPO was stable in its final days before listing. The GMP peaked at ₹150 on 13 September 2021. View the day-wise table above for the complete GMP history.
Explore Ami Organics IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
